Larvol Delta - Afmed-Reports-Promising-Phase-1-Efcacy-and-Safety-Data-for-AFM28-in-RelapsedRefractory-Acute-Myeloid-Leukemia-RR-AML

AFM28 - Affimed

https://www.globenewswire.com/news-release/2024/12/09/2994033/0/en/Affimed-Reports-Promising-Phase-1-Efficacy-and-Safety-Data-for-AFM28-in-Relapsed-Refractory-Acute-Myeloid-Leukemia-R-R-AML.html

Dec 9, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next